IntoCell, Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy (NCT07423117) | IntoCell, Inc | 2026-02-06 |
Track IntoCell, Inc automatically
Every clearance here is in the API, with alerts when new ones post.